Standard BioTools Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024
For the year, company expected revenue of approximately $174 million.
USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.410 USD | +6.02% |
|
+2.17% | -19.43% |